Functions of scavenger receptor class B, type i in atherosclerosis

Current Opinion in Lipidology

Volumn 23, Issue 5, 2012, Pages 487-491

  Mineo, Chieko ^a   Shaul, Philip W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

atherosclerosis; endothelium; high density lipoprotein cholesterol; macrophage; platelet; scavenger receptor class B; type I

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR BI;

ATHEROSCLEROSIS; BINDING AFFINITY; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; DNA POLYMORPHISM; DYSLIPIDEMIA; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; HUMAN; LYMPHOCYTE; MACROPHAGE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; REVIEW; THROMBOCYTE;

ANIMALS; ANTIGENS, CD36; ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; LIPID METABOLISM; LIPOPROTEINS, HDL; LIVER; MACROPHAGES; NITRIC OXIDE; PLATELET ACTIVATION; SEVERITY OF ILLNESS INDEX; STEM CELLS;

EID: 84866308224     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e328357ba61     Document Type: Review

References (72)

1. Acton SL, Scherer PE, Lodish HF, Krieger M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor.J Biol Chem 1994; 269:21003-21009. (Pubitemid 24266467)
2. Calvo D, Vega MA. Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. J Biol Chem 1993; 268:18929-18935. (Pubitemid 23273842)
3. Krieger M. Charting the fate of the 'good cholesterol': identification and characterization of the high-density lipoprotein receptor SR-BI. Annu Rev Biochem 1999; 68:523-558. (Pubitemid 29449202)
4. Acton S, Rigotti A, Landschulz KT, et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271:518-520.
5. Rigotti A, Trigatti B, Babitt J, et al. Scavenger receptor BI-a cell surface receptor for high density lipoprotein. Curr Opin Lipidol 1997; 8:181-188. (Pubitemid 27290465)
6. Krieger M. Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. J Clin Invest 2001; 108:793-797. (Pubitemid 32880286)
7. Brundert M, Ewert A, Heeren J, et al. Scavenger receptor classB typeI mediates the selective uptake of high-density lipoprotein-associated cholesteryl ester by the liver in mice. Arterioscler Thromb Vasc Biol 2005; 25:143-148. (Pubitemid 40054267)
8. Out R, Hoekstra M, Spijkers JA, et al. Scavenger receptor class B type I is solely responsible for the selective uptake of cholesteryl esters from HDL by the liver and the adrenals in mice. J Lipid Res 2004; 45:2088-2095. (Pubitemid 40990903)
9. Saddar S, Mineo C, Shaul PW. Signaling by the high-affinity HDL receptor scavenger receptor B type I. Arterioscler Thromb Vasc Biol 2010; 30:144-150.
10. Huby T, Doucet C, Dachet C, et al. Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissues. J Clin Invest 2006; 116:2767-2776. (Pubitemid 44511640)
11. Valiyaveettil M, Podrez EA. Platelet hyperreactivity, scavenger receptors and atherothrombosis. J Thromb Haemost 2009; 7 (Suppl. 1):218-221.
12. Van EM, Bos IS, Hildebrand RB, et al. Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development. Am J Pathol 2004; 165:785-794. (Pubitemid 39129286)
13. Hildebrand RB, Lammers B, Meurs I, et al. Restoration of high-density lipoprotein levels by cholesteryl ester transfer protein expression in scavenger receptor class B type I (SR-BI) knockout mice does not normalize pathologies associated with SR-BI deficiency. Arterioscler Thromb Vasc Biol 2010; 30:1439-1445.
14. Hogarth CA, Roy A, Ebert DL. Genomic evidence for the absence of a functional cholesteryl ester transfer protein gene in mice and rats. Comp Biochem Physiol B Biochem Mol Biol 2003; 135:219-229. (Pubitemid 36694192)
15. Schwartz CC, Van den Broek JM, Cooper PS. Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans. J Lipid Res 2004; 45: 1594-1607. (Pubitemid 39296198)
16. Guyard-Dangremont V, Desrumaux C, Gambert P, et al. Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility. Comp Biochem Physiol B Biochem Mol Biol 1998; 120:517-525. (Pubitemid 28386764)
17. Covey SD, Krieger M, Wang W, et al. Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells. Arterioscler Thromb Vasc Biol 2003; 23:1589-1594. (Pubitemid 37108202)
18. Mardones P, Quinones V, Amigo L, et al. Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice. J Lipid Res 2001; 42:170-180. (Pubitemid 32206827)
19. Rigotti A, Trigatti BL, Penman M, et al. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci USA 1997; 94:12610-12615. (Pubitemid 27492576)
20. Varban ML, Rinninger F, Wang N, et al. Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. Proc Natl Acad Sci USA 1998; 95:4619-4624. (Pubitemid 28207962)
21. Kozarsky KF, Donahee MH, Glick JM, et al. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 2000; 20:721-727. (Pubitemid 30151687)
22. Kozarsky KF, Donahee MH, Rigotti A, et al. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 1997; 387:414-417. (Pubitemid 27227207)
23. Arai T, Wang N, Bezouevski M, et al. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J Biol Chem 1999; 274:2366-2371.
24. Ji Y, Jian B, Wang N, et al. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 1997; 272: 20982-20985. (Pubitemid 27373951)
25. Ueda Y, Royer L, Gong E, et al. Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J Biol Chem 1999; 274:7165-7171.
26. Ueda Y, Gong E, Royer L, et al. Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics. J Biol Chem 2000; 275:20368-20373. (Pubitemid 30457612)
27. Wang N, Arai T, Ji Y, et al. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice. J Biol Chem 1998; 273:32920-32926. (Pubitemid 28557684)
28. Out R, Hoekstra M, de Jager SC, et al. Adenovirus-mediated hepatic over-expression of scavenger receptor class B type I accelerates chylomicron metabolism in C57BL/6J mice. J Lipid Res 2005; 46:1172-1181. (Pubitemid 43109832)
29. Tall AR, Yvan-Charvet L, Terasaka N, et al. HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab 2008; 7:365-375. (Pubitemid 351598023)
30. Wang X, Collins HL, Ranalletta M, et al. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J Clin Invest 2007; 117:2216-2224. (Pubitemid 47219566)
31. Zhang W, Yancey PG, Su YR, et al. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 2003; 108:2258-2263. (Pubitemid 37363044)
32. Cai SF, Kirby RJ, Howles PN, Hui DY. Differentiation-dependent expression and localization of the class B type I scavenger receptor in intestine. J Lipid Res 2001; 42:902-909. (Pubitemid 32545845)
33. Hauser H, Dyer JH, Nandy A, et al. Identification of a receptor mediating absorption of dietary cholesterol in the intestine. Biochemistry (Mosc) 1998; 37:17843-17850. (Pubitemid 29023939)
34. Levy E, Menard D, Suc I, et al. Ontogeny, immunolocalisation, distribution and function of SR-BI in the human intestine. J Cell Sci 2004; 117:327-337. (Pubitemid 38128910)
35. Chinetti G, Gbaguidi FG, Griglio S, et al. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation 2000; 101:2411-2417. (Pubitemid 30329133)
36. Hirano K, Yamashita S, Nakagawa Y, et al. Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions. Circ Res 1999; 85:108-116. (Pubitemid 29321047)
37. Feng H, Guo L, Wang D, et al. Deficiency of scavenger receptor BI leads to impaired lymphocyte homeostasis and autoimmune disorders in mice. Arterioscler Thromb Vasc Biol 2011; 31:2543-2551.
38. Campbell KA, Lipinski MJ, Doran AC, et al. Lymphocytes and the adventitial immune response in atherosclerosis. Circ Res 2012; 110:889-900.
39. Norata GD, Pirillo A, Catapano AL. HDLs, immunity, and atherosclerosis. Curr Opin Lipidol 2011; 22:410-416.
40. Guo L, Song Z, Li M, et al. Scavenger receptor BI protects against septic death through its role in modulating inflammatory response. J Biol Chem 2009; 284:19826-19834.
41. Mineo C, Shaul PW. HDL stimulation of endothelial nitric oxide synthase. A novel mechanism of HDL action. Trends Cardiovasc Med 2003; 13:226-231. (Pubitemid 36960169)
42. Yuhanna IS, Zhu Y, Cox BE, et al. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat Med 2001; 7:853-857. (Pubitemid 32691642)
43. Seetharam D, Mineo C, Gormley AK, et al. High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res 2006; 98:63-72. (Pubitemid 43970204)
44. Mineo C, Yuhanna IS, Quon MJ, Shaul PW. High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases. J Biol Chem 2003; 278:9142-9149. (Pubitemid 36800395)
45. Assanasen C, Mineo C, Seetharam D, et al. Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling. J Clin Invest 2005; 115:969-977. (Pubitemid 40489401)
46. Ikemoto M, Arai H, Feng D, et al. Identification of a PDZ-domain-containing protein that interacts with the scavenger receptor class B type I. Proc Natl Acad Sci USA 2000; 97:6538-6543. (Pubitemid 30412749)
47. Zhu W, Saddar S, Seetharam D, et al. The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity. Circ Res 2008; 102:480-487. (Pubitemid 351651102)
48. Kocher O, Yesilaltay A, Shen CH, et al. Influence of PDZK1 on lipoprotein metabolism and atherosclerosis. Biochim Biophys Acta 2008; 1782:310-316.
49. Kocher O, Yesilaltay A, Cirovic C, et al. Targeted disruption of the PDZK1 gene in mice causes tissue-specific depletion of the high density lipoprotein receptor scavenger receptor class B type I and altered lipoprotein metabolism. J Biol Chem 2003; 278:52820-52825. (Pubitemid 38035880)
50. Yesilaltay A, Kocher O, Pal R, et al. PDZK1 is required for maintaining hepatic scavenger receptor, class B, type I (SR-BI) steady state levels but not its surface localization or function. J Biol Chem 2006; 281:28975-28980. (Pubitemid 44507041)
51. Mineo C, Deguchi H, Griffin JH, Shaul PW. Endothelial and antithrombotic actions of HDL. Circ Res 2006; 98:1352-1364. (Pubitemid 43948059)
52. Feng Y, Van EM, Van CE, et al. Critical role of scavenger receptor-BI-expressing bone marrow-derived endothelial progenitor cells in the attenuation of allograft vasculopathy after human apo A-I transfer. Blood 2009; 113:755-764.
53. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8:1227-1234. (Pubitemid 35373553)
54. Imachi H, Murao K, Cao W, et al. Expression of human scavenger receptor B1on and in human platelets. Arterioscler Thromb Vasc Biol 2003; 23:898-904. (Pubitemid 36566184)
55. Valiyaveettil M, Kar N, Ashraf MZ, et al. Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI. Blood 2008; 111:1962-1971. (Pubitemid 351451506)
56. Brodde MF, Korporaal SJ, Herminghaus G, et al. Native high-density lipo-proteins inhibit platelet activation via scavenger receptor BI: role of negatively charged phospholipids. Atherosclerosis 2011; 215:374-382.
57. Nofer JR, Brodde MF, Kehrel BE. High-density lipoproteins, platelets and the pathogenesis of atherosclerosis. Clin Exp Pharmacol Physiol 2010; 37:726-735.
58. Nofer JR, Walter M, Kehrel B, et al. HDL3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositide-derived second messengers 1, 2-diacylgly-cerol and inositol 1, 4, 5-tris-phosphate. Arterioscler Thromb Vasc Biol 1998; 18:861-869. (Pubitemid 28272578)
59. Dole VS, Matuskova J, Vasile E, et al. Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 2008; 28:1111-1116.
60. Korporaal SJ, Meurs I, Hauer AD, et al. Deletion of the high-density lipoprotein receptor scavenger receptor BI in mice modulates thrombosis susceptibility and indirectly affects platelet function by elevation of plasma free cholesterol. Arterioscler Thromb Vasc Biol 2011; 31:34-42.
61. Ma Y, Ashraf MZ, Podrez EA. Scavenger receptor BI modulates platelet reactivity and thrombosis in dyslipidemia. Blood 2010; 116:1932-1941.
62. Acton S, Osgood D, Donoghue M, et al. Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol 1999; 19:1734-1743. (Pubitemid 29323833)
63. Osgood D, Corella D, Demissie S, et al. Genetic variation at the scavenger receptor class B type I gene locus determines plasma lipoprotein concentrations and particle size and interacts with type 2 diabetes: the Framingham study. J Clin Endocrinol Metab 2003; 88:2869-2879. (Pubitemid 36724469)
64. West M, Greason E, Kolmakova A, et al. Scavenger receptor class B type I protein as an independent predictor of high-density lipoprotein cholesterol levels in subjects with hyperalphalipoproteinemia. J Clin Endocrinol Metab 2009; 94:1451-1457.
65. Hsu LA, Ko YL, Wu S, et al. Association between a novel 11-base pair deletion mutation in the promoter region of the scavenger receptor class B type I gene and plasma HDL cholesterol levels in Taiwanese Chinese. Arterioscler Thromb Vasc Biol 2003; 23:1869-1874. (Pubitemid 37254877)
66. Vergeer M, Korporaal SJ, Franssen R, et al. Genetic variant of the scavenger receptor BI in humans. N Engl J Med 2011; 364:136-145.
67. Di AE, Sarwar N, Perry P, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009; 302:1993-2000.
68. Lewington S, Whitlock G, Clarke R, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55, 000 vascular deaths. Lancet 2007; 370:1829-1839.
69. Voight BF, Peloso GM, Orho-Melander M, et al. Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study. Lancet 2012. doi: 10.1016/S0140-6736(12)60312-2.
70. Besler C, Heinrich K, Rohrer L, et al. Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. J Clin Invest 2011; 121:2693-2708.
71. Chaudhury H, Raborn E, Goldie LC, Hirschi KK. Stem cell-derived vascular endothelial cells and their potential application in regenerative medicine. Cells Tissues Organs 2012; 195:41-47.
72. Takayama N, Nishimura S, Nakamura S, et al. Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med 2010; 207:2817-2830.